Industry Outlook
The Electrodermal activity detecting devices market is set project promising growth at a compounded annual growth rate (CAGR) of 8.7% during the forecast period from 2019 to 2027. Electodermal activity detection is also known as galvanic skin response employs sensors for measuring and detecting human stress and different emotional activities. The important parameters assessed by employing EDA devices are arousal detection, emotional cartography, relaxation biofeedback etc.
Market Synopsis
Get a sample copy for more information
"Rising prevalence of mental disorders and increasing demand for creating novel technologies to measure sudomotor nerve activities drives the psychological arousal market growth"
Electrodermal activity detecting (EDA) wearable devices are being widely employed in psychiatric medical studies to understand the various mental disorders and its early detection. Currently psychological awareness is dominating the application segment for electrodermal activity detecting devices market. Rising prevalence of mental disorders and increasing demand for creating novel technology to measure sudomotor nerve activities drives the psychological arousal market growth. The rationale behind the development of this EDA technology is to create an excellent human-machine interface to understand different emotional states and provide optimum mental health management. Under the influence of sympathetic nervous system the device measures the changes in skin conductivity by placing the electrodes at specific sites such as hand palms and feet soles etc. Physiological arousal will garner tremendous attention owing to increasing demand to understand risk perception associated with workers safety and decision making process and drastically reduce profession associated trauma and accident cases.
Get a sample copy for more information
"Existence of developed medical device industries and increasing public health awareness pertaining to electrodermal activity detecting wearable devices together drive the market growth in North America region"
North America is clearly spearheading the regional segment for electrodermal activity detecting devices market representing a market share of 45%. The major criterions related to its overwhelming market growth are establishment of developed medical device industries manufacturing state of the art medical gadgets and increasing public health awareness pertaining to electrodermal activity detecting wearable devices. Europe is placed in the second position holding a share of 30% owing to the strategic collaboration between medical device companies and academic research institutes to develop technology pertaining to electrodermal activity detecting devices. European Medical Agency (EMA), has adopted a proactive role in granting early CE approval for medical devices used in medical diagnosis and monitoring mental activities. Asia Pacific currently holds 15% market share and is set to register impressive market growth during the forecast period owing to developing healthcare infrastructure and lucrative market opportunities for medical device manufacturers to establish subsidiaries.
Get a sample copy for more information
Historical & Forecast Period
This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.
Report Scope by Segments
The market is segmented by application and by geography.
| ATTRIBUTE |
DETAILS |
| Research Period |
2017-2027 |
| Base Year |
2018 |
| Forecast Period |
2019-2027 |
| Historical Year |
2017 |
| Unit |
USD Million |
| Segmentation |
By Application (2017–2027; US$ Mn)
• Physiological Arousal
• Psychological Arousal
• Perioperative Care
• Others
|
|
Geography Segment (2017–2027; US$ Mn)
• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of APAC)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of Middle East and Africa)
|
Medical device manufacturers competing in the electrodermal activity detecting devices market are BrainSigns, Srl, Eisco Labs, iMotions, Movisens GmbH, Maxim Integrated, PLUX Wireless Biosignals S.A., Shimmer and Vernier Software & Technology, LLC.
Key questions answered in this report
- Which medical device companies are competing in the electrodermal activity detecting devices market?
- What are the latest strategic collaboration, merger and acquisitions taking place in the electrodermal activity detecting devices market?
- Brief explanation of the technology employed in EDA and its application as an human machine interface to understand human emotions and changing skin conductance?
- Which psychological attributes are assessed using EDA technologies?
- What is the market performance in North America, Europe and Asia Pacific region?
